Document type
ArticlePublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/153437
Dupilumab Improves Nasal Polyp Burden and Asthma Control in Patients With CRSwNP and AERD
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
In the difficult-to-treat subgroup of patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and comorbid aspirin-exacerbated respiratory disease, dupilumab significantly improved CRSwNP disease outcomes, along with asthma control and lung function. This is preliminary evidence of the effect of dupilumab in patients with CRSwNP and comorbid aspirin- exacerbated respiratory disease.
Citation
Citation
LAIDLAW, Tanya M., et al. Dupilumab Improves Nasal Polyp Burden and Asthma Control in Patients With CRSwNP and AERD. The Journal of Allergy and Clinical Immunology: In Practice. 2019. Vol. 7, num. 7, pags. 2462-2465. [consulted: 14 of May of 2026]. Available at: https://hdl.handle.net/2445/153437